EraGen Biosciences

Madison, United States Founded: 1994 • Age: 32 yrs Acquired By Luminex
Molecular reagents and diagnostic assays for disease detection are developed.

About EraGen Biosciences

EraGen Biosciences is a company based in Madison (United States) founded in 1994 was acquired by Luminex in June 2011.. EraGen Biosciences has raised $12 million across 2 funding rounds from investors including Novartis, Luminex Corporation and HHS. EraGen Biosciences operates in a competitive market with competitors including ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others.

  • Headquarter Madison, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12 M (USD)

    in 2 rounds

  • Latest Funding Round
    $99.96 K (USD), Grant

    Sep 02, 2008

  • Investors
    Novartis

    & 5 more

  • Employee Count
    Employee Count
  • Acquired by
    Luminex

    (Jun 21, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of EraGen Biosciences

EraGen Biosciences has successfully raised a total of $12M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $99.96 thousand completed in September 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $99,960
  • First Round

    (09 Jan 2006)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2008 Amount Grant - EraGen Biosciences Valuation

investors

HHS
Jan, 2006 Amount Series A - EraGen Biosciences Valuation First Analysis , Prolog Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in EraGen Biosciences

EraGen Biosciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Luminex Corporation and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital and transaction advisory services for B2B tech companies.
Founded Year Domain Location
Health-focused venture capital investments are made in US sectors.
Founded Year Domain Location
US private equity investments are managed by Stonehenge Capital.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by EraGen Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - EraGen Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Eragen Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of EraGen Biosciences

EraGen Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Speech recognition solutions are provided by Inscripta for healthcare professionals.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Genomic and theranostic services for oncology precision medicine are delivered.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Develops tools and products for research and clinical application
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about EraGen Biosciences

When was EraGen Biosciences founded?

EraGen Biosciences was founded in 1994 and raised its 1st funding round 12 years after it was founded.

Where is EraGen Biosciences located?

EraGen Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.

Is EraGen Biosciences a funded company?

EraGen Biosciences is a funded company, having raised a total of $12M across 2 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Jan 09, 2006.

What does EraGen Biosciences do?

EraGen Biosciences was founded in 1994 in Madison, United States, operating in the biotechnology sector. Molecular diagnostic assays and reagents for early detection of cancer, genetic, and infectious diseases are developed, manufactured, and marketed for research and clinical use. Analysis software, including MultiCode-PLx and MultiCode-RTx, is provided to support customized testing. Products are distributed through partners in the United States and Canada. Acquisition by Luminex Corporation occurred in 2011.

Who are the top competitors of EraGen Biosciences?

EraGen Biosciences's top competitors include Sino Biological, OncoDNA and ArcherDX.

Who are EraGen Biosciences's investors?

EraGen Biosciences has 6 investors. Key investors include Novartis, Luminex Corporation, HHS, First Analysis, and Prolog Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available